Besides mutations, BRCA1 is silenced through promoter hypermethylation in some breast or ovarian cancers, causing diminished BRCA1 expression level similar to the BRCA1 status in Brca1−/− mice. The gene discussed is BRCA1; the disease is ovarian cancer.